If your BMI is close to a threshold, gathering these additional data points gives your provider more ammunition to advocate on your behalf
This specific combination has not undergone the clinical trial process required for FDA approval
The efficacy and safety of tirzepatide in patients with diabetes and/or obesity: systematic review and meta-analysis of randomized clinical trials
GLP-1 receptor agonists are typically initiated when lifestyle modifications and first-line oral antidiabetic agents (such as metformin) have not achieved adequate glycaemic control
Studies have shown that patients using GLP-1 receptor agonists, alongside lifestyle modifications, can achieve an average weight reduction of 1015% of their body weight over time with improvements in blood sugar control, blood pressure, and cholesterol levels
Cao J, Zhang K, Zheng J, Dong R